Chairperson of the Manikchand Group of Industries, Rasiklal M Dhariwal dies due to salivary gland cancer and sepsis at a hospital in Pune.
Rasiklal M Dhariwal dies of cancer at 78
HIGHLIGHTS
- Rasiklal M Dhariwal dies at the age of 78 at a hospital in Pune
- He had been on life support system for 15 days
- Dhariwal died due to multiple organ failure and sepsis
Chairperson of the Manikchand group, Rasiklal M Dhariwal dies at the age of 78 at a hospital in Pune on Tuesday. He has been going through a treatment for the salivary gland cancer. When he was diagnosed with pneumonia, he was admitted to the Ruby Hall Clinic Hospital in Pune. On 4th September he had been admitted to the hospital. Doctors revealed that he had been on life support system for 15 days and died due to sepsis and multiple organ failure. Dhariwal demised on Tuesday at 8.15 pm, Medical Director of the hospital Dr Sanjay Pathare informed.
Dhariwal had been diagnosed with salivary gland cancer (parotid cancer) a year ago and was receiving treatment for the same at HCG cancer hospital, Bengaluru and Ruby Hall Clinic Hospital in Pune.
The Manikchand group of industries in India is recognized as a company that produces chewable tobacco products. Dhariwal inherited this business from his father and started his career with a bidi factory. Later, he progressed to the production of gutka or chewable tobacco and soon became the gutka baron. He was known to be close to a number of political leaders in the country. For 21 years, he was the president of the Shirur Municipal council which was also headed by his son. Dhariwal survived by his wife, a son and four daughters.
DoctorNDTV is the one stop site for all your health needs providing the most credible health information, health news and tips with expert advice on healthy living, diet plans, informative videos etc. You can get the most relevant and accurate info you need about health problems like diabetes, cancer, pregnancy, HIV and AIDS, weight loss and many other lifestyle diseases. We have a panel of over 350 experts who help us develop content by giving their valuable inputs and bringing to us the latest in the world of healthcare.
